Home Stock

Stock Research: Kalbe Farma

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Kalbe Farma

IDX:KLBF ID1000125107
100
  • Value
    88
  • Growth
    35
  • Safety
    Safety
    88
  • Combined
    96
  • Sentiment
    100
  • 360° View
    360° View
    100
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PT Kalbe Farma Tbk is an Indonesian company engaged in developing, manufacturing, and trading pharmaceutical products. It operates in the pharmaceutical, consumer health, nutritional, and distribution industries. The company primarily operates in Indonesia. In the last fiscal year, the company had a market cap of $4,349 million, profits of $778 million, and revenue of $2,028 million, with 12,903 employees.

more
Strongest Rank Growth
Weakest Rank Sentiment
Country Indonesia
Industry Pharmaceuticals
Size Medium
Website kalbe.co.id
Index
IDX Composite
Kalbe Farma stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 77 69 69
Growth
35 17 17 45
Safety
Safety
88 79 79 81
Sentiment
100 99 63 79
360° View
360° View
100 89 65 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
89 76 38 69
Opinions Change
61 56 50 50
Pro Holdings
n/a 100 35 16
Market Pulse
74 100 95 95
Sentiment
100 99 63 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 77 69 69
Growth
35 17 17 45
Safety Safety
88 79 79 81
Combined
96 75 61 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
84 70 58 48
Price vs. Earnings (P/E)
76 73 69 65
Price vs. Book (P/B)
66 66 59 55
Dividend Yield
90 77 74 68
Value
88 77 69 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
40 25 23 27
Profit Growth
47 57 26 45
Capital Growth
43 20 92 85
Stock Returns
43 29 9 37
Growth
35 17 17 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 74 62 70
Refinancing
83 80 74 78
Liquidity
73 50 72 61
Safety Safety
88 79 79 81

Similar Stocks

Discover high‑ranked alternatives to Kalbe Farma and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Brazilian Electric

BOVESPA:ELET6
Country: Brazil
Industry: Electric Utilities
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews